ReWalk Robotics Ltd.

1.75
-0.12 (-6.42%)
At close: Mar 21, 2025, 3:59 PM
1.74
-0.10%
After-hours: Mar 21, 2025, 07:00 PM EDT
-6.42%
Bid 1.7
Market Cap 18.55M
Revenue (ttm) 30.97M
Net Income (ttm) -34.93M
EPS (ttm) -3.33
PE Ratio (ttm) -0.52
Forward PE -1.57
Analyst Buy
Ask 1.78
Volume 437,548
Avg. Volume (20D) 2,668,486
Open 1.87
Previous Close 1.87
Day's Range 1.69 - 1.84
52-Week Range 1.25 - 6.00
Beta 1.74

About LFWD

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabil...

Sector Healthcare
IPO Date Sep 12, 2014
Employees 80
Stock Exchange NASDAQ
Ticker Symbol LFWD
Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for LFWD stock is "Buy." The 12-month stock price forecast is $11.5, which is an increase of 559.03% from the latest price.

Stock Forecasts

Next Earnings Release

ReWalk Robotics Ltd. is scheduled to release its earnings on May 14, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+8.84%
Lifeward shares are trading higher after the compa... Unlock content with Pro Subscription
1 month ago
+33.57%
Lifeward shares are trading higher after Laidlaw & Co. initiated coverage on the stock with a Buy rating and announced a price target of $10.